Detalles de la búsqueda
1.
Genetics and beyond: Precision Medicine Real-World Data for Patients with Cervical, Vaginal or Vulvar Cancer in a Tertiary Cancer Center.
Int J Mol Sci
; 25(4)2024 Feb 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38397025
2.
De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR-): survival outcomes from a multicentre, open-label, randomised, phase 2 trial.
Lancet Oncol
; 23(5): 625-635, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35405088
3.
Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial.
Breast Cancer Res
; 24(1): 58, 2022 09 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36056374
4.
The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer-a pooled analysis of the randomised clinical trials PlanB and SUCCESS C.
Br J Cancer
; 126(12): 1715-1724, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35194193
5.
Changes in gynecologic and breast cancer diagnoses during the first wave of the COVID-19 pandemic: analysis from a tertiary academic gyneco-oncological center in Germany.
Arch Gynecol Obstet
; 305(3): 713-718, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34491417
6.
The role of E-Cadherin expression in primary site of breast cancer.
Arch Gynecol Obstet
; 305(4): 913-920, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34510244
7.
Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist's Decision on Systemic Therapy in a Real-World Setting.
Int J Mol Sci
; 23(15)2022 Aug 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35955851
8.
NGS-guided precision oncology in metastatic breast and gynecological cancer: first experiences at the CCC Munich LMU.
Arch Gynecol Obstet
; 303(5): 1331-1345, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33277683
9.
Association of TILs with clinical parameters, Recurrence Score® results, and prognosis in patients with early HER2-negative breast cancer (BC)-a translational analysis of the prospective WSG PlanB trial.
Breast Cancer Res
; 22(1): 47, 2020 05 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-32408905
10.
Efficacy of deescalated chemotherapy according to PAM50 subtypes, immune and proliferation genes in triple-negative early breast cancer: Primary translational analysis of the WSG-ADAPT-TN trial.
Int J Cancer
; 146(1): 262-271, 2020 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31162838
11.
Differential impact of prognostic parameters in hormone receptor-positive lobular breast cancer.
Cancer
; 126(22): 4847-4858, 2020 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32780421
12.
Preexisting musculoskeletal burden and its development under letrozole treatment in early breast cancer patients.
Int J Cancer
; 145(8): 2114-2121, 2019 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30901076
13.
Correction to: Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial.
Breast Cancer Res Treat
; 175(1): 265-266, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30632020
14.
Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer.
Breast Cancer Res Treat
; 174(2): 453-461, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30603996
15.
Pattern of care of adjuvant radiotherapy in male breast cancer patients in clinical practice: an observational study.
Strahlenther Onkol
; 195(4): 289-296, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30046931
16.
Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study.
BMC Cancer
; 19(1): 611, 2019 Jun 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31227025
17.
Recover your smile: Effects of a beauty care intervention on depressive symptoms, quality of life, and self-esteem in patients with early breast cancer.
Psychooncology
; 28(2): 401-407, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30511433
18.
EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer.
BMC Cancer
; 18(1): 431, 2018 04 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-29661238
19.
Evaluation of an interdisciplinary palliative care inhouse training for professionals in gynecological oncology.
Arch Gynecol Obstet
; 297(3): 767-773, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29362923
20.
Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial.
Breast Cancer Res Treat
; 165(3): 573-583, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28664507